Picture of T. Rowe Price logo

TROW — T. Rowe Price News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedLarge CapSuper Stock

Brief: Maplight Therapeutics Inc - Initial Public Offering Price Is $17.00 Per Share

Oct 6 (Reuters) - Goldman Sachs Group Inc GS.N:

MAPLIGHT THERAPEUTICS INC -  INITIAL PUBLIC OFFERING PRICE IS $17.00 PER SHARE

MAPLIGHT THERAPEUTICS INC SEES IPO OF 14.75 MILLION SHARES OF COMMON STOCK - SEC FILING

MAPLIGHT THERAPEUTICS - AFFILIATES OF GOLDMAN SACHS & CO. LLC ARE EXPECTED TO PURCHASE 476,707 SHARES OF COMMON STOCK IN CONCURRENT PRIVATE PLACEMENT

MAPLIGHT THERAPEUTICS - ACCOUNTS ADVISED BY T. ROWE PRICE INVESTMENT MANAGEMENT INDICATED INTEREST IN PURCHASING UP TO $40 MILLION IN SHARES AT IPO PRICE

Source text: [ID:n0001193125-25-231829]

Further company coverage: GS.N

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on T. Rowe Price

See all news